Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Outcomes of eltrombopag combined with immunosuppressive therapy in adults with severe aplastic anemia: A large, propensity-matched retrospective analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

SSSaifullah Syed

Discussion

Loading...

Member takes

Overview

Retrospective analysis reveals eltrombopag improves partial response rates but impacts survival in adults with severe aplastic anemia.

Key Points

  • To assess the efficacy and safety of adding eltrombopag to immunosuppressive therapy in adults with severe aplastic anemia.
  • Retrospective cohort study using TriNetX database
  • Comparison of outcomes in patients receiving eltrombopag plus immunosuppressive therapy and those receiving only immunosuppressive therapy
  • Propensity score matching for analysis
  • Higher overall complete response rates in immunosuppressive therapy alone group at 6 and 12 months
  • Elevated partial response rates in the eltrombopag group at both time points
  • Higher 12-month mortality risk in the eltrombopag group, reduced after adjusting for blood transfusions

Cite This Study

Saifullah Syed (2025) studied this question.

synapsesocial.com/papers/69362f444fa91c937236d58bhttps://doi.org/10.1182/blood-2025-3201
View Full Paper
Ask AI
Bookmark
Share